B Balkau

Author PubWeight™ 164.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Circulation 2010 7.03
2 Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med 1999 5.59
3 A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010 4.52
4 Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998 3.71
5 Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 2004 3.26
6 Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 2011 2.43
7 Age, body mass index and Type 2 diabetes-associations modified by ethnicity. Diabetologia 2003 2.37
8 Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. N Engl J Med 1994 2.31
9 Maternal effect and familial aggregation in NIDDM. The CODIAB Study. CODIAB-INSERM-ZENECA Study Group. Diabetes 1994 2.04
10 Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 2011 2.00
11 Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 2013 1.93
12 A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 1991 1.92
13 [An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): epidemiologic data on the insulin resistance syndrome]. Rev Epidemiol Sante Publique 1996 1.86
14 Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009 1.81
15 The prevalence of hypertension in rural and urban Cameroon. Int J Epidemiol 1998 1.68
16 Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon. Diabetologia 1997 1.65
17 Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia 2012 1.55
18 All the evidence points to alcohol being implicated in the recent changes in mortality in Russia. Ann Epidemiol 1999 1.53
19 Adherence measured by microtiter assay as a virulence marker for Staphylococcus epidermidis infections. J Clin Microbiol 1990 1.50
20 Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon. J Epidemiol Community Health 2009 1.47
21 Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr 2012 1.46
22 Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome). Diabetes Metab 2005 1.44
23 The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study. Diabetologia 1984 1.32
24 Common genetic variation near MC4R is associated with eating behaviour patterns in European populations. Int J Obes (Lond) 2009 1.30
25 Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care 1999 1.30
26 Determinants and nature of dietary underreporting in a free-living population: the Fleurbaix Laventie Ville Santé (FLVS) Study. Int J Obes Relat Metab Disord 1997 1.30
27 Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study. Diabetologia 2012 1.29
28 The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia 2012 1.28
29 Distribution of fasting serum insulin measured by enzyme immunoassay in an unselected population of 4,032 individuals. Reference values according to age and sex. D.E.S.I.R. Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance. Diabetes Metab 1996 1.27
30 Diabetes as a risk factor for sudden death. Lancet 1999 1.27
31 Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000 1.26
32 The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 1997 1.25
33 Case counting in epidemiology: limitations of methods based on multiple data sources. Int J Epidemiol 1996 1.24
34 Diabetes mellitus, hyperglycaemia and cancer. Diabetes Metab 2010 1.23
35 Inappropriateness and variability of antibiotic prescription among French office-based physicians. J Clin Epidemiol 1998 1.21
36 Trends in antimicrobial drug use in the community--France, 1981-1992. J Infect Dis 1998 1.20
37 Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis. Diabetologia 2006 1.19
38 Association between heart rate-corrected QT interval and coronary risk factors in 2,894 healthy subjects (the DESIR Study). Data from an Epidemiological Study on the Insulin Resistance syndrome. Am J Cardiol 2000 1.19
39 Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study. Diabetologia 2012 1.17
40 Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study. Diabetes Care 2001 1.16
41 Death certificate coding practices related to diabetes in European countries--the 'EURODIAB Subarea C' Study. Int J Epidemiol 1992 1.12
42 Reproducibility of HbA1c in a healthy adult population: the Telecom Study. Diabetes Care 1999 1.12
43 Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract 2006 1.11
44 Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia 2006 1.10
45 The habitual diet in rural and urban Cameroon. Eur J Clin Nutr 2000 1.10
46 Hypertension in four African-origin populations: current 'Rule of Halves', quality of blood pressure control and attributable risk of cardiovascular disease. J Hypertens 2001 1.09
47 Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R., Three City, PRIME, and SU.VI.MAX studies. Eur J Cardiovasc Prev Rehabil 2011 1.08
48 High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. Int J Epidemiol 1998 1.08
49 Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet 2007 1.08
50 [Prevalence of symptoms of sleep apnea syndrome. Study of a French middle-aged population]. Rev Mal Respir 2007 1.08
51 Revision of diagnostic criteria for diabetes. Lancet 1996 1.08
52 The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. Diabetologia 2006 1.07
53 Sick genes, sick individuals or sick populations with chronic disease? The emergence of diabetes and high blood pressure in African-origin populations. Int J Epidemiol 2001 1.07
54 Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population. Int J Obes (Lond) 2012 1.06
55 Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest 2000 1.05
56 Insulin: in search of a syndrome. Diabet Med 2002 1.05
57 Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial. Diabetes Care 2001 1.04
58 Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids. Diabetologia 2008 1.04
59 Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007. Diabetologia 2009 1.03
60 Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the D.E.S.I.R. cohort. Int J Epidemiol 2005 1.03
61 Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol 1994 1.03
62 Bimodality in glucose tolerance distributions in the urban Polynesian population of Western Samoa. Diabetes Res 1984 1.02
63 Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levels. Eur J Endocrinol 2009 1.01
64 The metabolic syndrome in smokers. The D.E.S.I.R. study. Diabetes Metab 2003 1.01
65 Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes. Diabetes Obes Metab 2012 1.00
66 Species identification, antibiotic sensitivity and slime production of coagulase-negative staphylococci isolated from clinical specimens. Epidemiol Infect 1988 1.00
67 Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol 1997 1.00
68 The high prevalence of diabetes mellitus, impaired glucose tolerance and diabetic retinopathy in Nauru--the 1982 survey. Diabetes Res 1984 0.99
69 What does postprandial hyperglycaemia mean? Diabet Med 2004 0.99
70 Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: the role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetologia 2009 0.99
71 Factors associated with the development of diabetes in the Micronesian population of Nauru. Am J Epidemiol 1985 0.97
72 Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia 2012 0.97
73 Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age? Diabet Med 2005 0.96
74 Underreporting of energy intake in four populations of African origin. Int J Obes Relat Metab Disord 2000 0.95
75 Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology 1999 0.95
76 HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study. Diabetologia 2009 0.95
77 A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetes. Diabetes Obes Metab 2013 0.94
78 Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort. Diabetologia 2009 0.94
79 Serum bile acids and cholestasis in alcoholic hepatitis. Relationship with usual liver tests and histological features. J Hepatol 1994 0.94
80 Impact of objectively measured sedentary behaviour on changes in insulin resistance and secretion over 3 years in the RISC study: interaction with weight gain. Diabetes Metab 2013 0.94
81 Waist circumference and obesity-related abnormalities in French and Cameroonian adults: the role of urbanization and ethnicity. Int J Obes (Lond) 2010 0.92
82 Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study. Diabetologia 2010 0.92
83 Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels. Diabetologia 2013 0.91
84 Alcohol intake and fasting insulin in French men and women. The D.E.S.I.R. Study. Diabetes Metab 2002 0.91
85 Development of food frequency questionnaires in three population samples of African origin from Cameroon, Jamaica and Caribbean migrants to the UK. Eur J Clin Nutr 1996 0.91
86 Selection for Linkage Modification II. a Recombination Balance for Neutral Modifiers. Genetics 1973 0.90
87 Relationships between abdominal body fat distribution and cardiovascular risk factors: an explanation for women's healthier cardiovascular risk profile. The D.E.S.I.R. Study. Int J Obes Relat Metab Disord 1999 0.90
88 Diabetic retinopathy in Nauruans. Am J Epidemiol 1983 0.88
89 Alcohol consumption and risk of type 2 diabetes in European men and women: influence of beverage type and body size The EPIC-InterAct study. J Intern Med 2012 0.88
90 Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group. Kidney Int 2000 0.88
91 Trends in aspirin, paracetamol and non-steroidal anti-inflammatory drug use in children between 1981 and 1992 in France. Eur J Clin Pharmacol 1998 0.87
92 Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study. BMJ 1998 0.87
93 Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study. Int J Obes (Lond) 2011 0.87
94 ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study. Diabetologia 2007 0.86
95 Effect of maternal diabetes on the pattern of selected insulin resistance syndrome parameters in normal glucose tolerant subjects of two Algonquin Indian communities in Quebec. Diabetes Care 1996 0.86
96 Blood glucose distribution and prevalence of diabetes in Hanoi (Vietnam). Am J Epidemiol 1994 0.86
97 Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women? J Cardiovasc Risk 2001 0.85
98 Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes. Diabetes Metab 2007 0.85
99 Re: "A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus". Am J Epidemiol 1991 0.85
100 The prevalence of overweight and obesity, and distribution of waist circumference, in adults and children in the French Overseas Territories: the PODIUM survey. Diabetes Metab 2012 0.84
101 Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study. Diabet Med 2011 0.84
102 [Insulin sensitivity and ethnic groups]. Diabetes Metab 2001 0.84
103 Influence of blood glucose on heart rate and cardiac autonomic function. The DESIR study. Diabet Med 2011 0.83
104 Hyperglycaemia: link to excess mortality. Int J Clin Pract Suppl 2001 0.83
105 Comment to: Borch-Johnsen K, Colagiuri S, Balkau B et al. (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396-1402. Diabetologia 2005 0.82
106 Habitual diet in four populations of African origin: a descriptive paper on nutrient intakes in rural and urban Cameroon, Jamaica and Caribbean migrants in Britain. Public Health Nutr 2001 0.82
107 Assessment of diabetes screening by general practitioners in France: the EPIDIA Study. Diabet Med 2006 0.82
108 Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies. Diabet Med 2011 0.82
109 Risk factors for diabetes in three Pacific populations. Am J Epidemiol 1984 0.82
110 The frequency of alcoholisation among young people injured in accidents in France. Alcohol Alcohol 1991 0.82
111 Smoking, type 2 diabetes and metabolic syndrome. Diabetes Metab 2004 0.81
112 New diagnostic criteria for diabetes and mortality in older adults. DECODE Study Group. European Diabetes Epidemiology Group. Lancet 1999 0.81
113 Gender-specific differences in carotid intima-media thickness and its progression over three years: a multicenter European study. Nutr Metab Cardiovasc Dis 2011 0.81
114 Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients. Diabetes Metab 2005 0.81
115 Oral contraceptives, insulin resistance and ischemic vascular disease. Int J Gynaecol Obstet 1990 0.81
116 Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging. Radiology 1991 0.81
117 Fibrinogen: a possible link between alcohol consumption and cardiovascular disease? DESIR Study Group. Arterioscler Thromb Vasc Biol 1999 0.81
118 Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial. Hepatology 1992 0.81
119 Evidence for distinct effects of GH and IGF-I in the metabolic syndrome. Diabet Med 2007 0.81
120 Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group. J Hepatol 1999 0.80
121 Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue. Hepatology 1994 0.80
122 [Analysis of diabetes-related mortality in France (1970-1987) from multiple causes of death]. Diabete Metab 1991 0.80
123 Tissue-type plasminogen activator antigen and consumption of dairy products. The DESIR study. Data from an Epidemiological Study on Insulin Resistance Syndrome. Thromb Res 1999 0.80
124 Arterial hypertension in the adult population of Guadeloupe, and associated factors in subjects of African origin. Rev Epidemiol Sante Publique 1996 0.80
125 Android fat distribution by age and sex. The waist hip ratio. Diabete Metab 1993 0.79
126 A study of the 3-year incidence of diabetic retinopathy in a French diabetic population seen at Lariboisière Hospital, Paris. Diabetes Metab 2012 0.78
127 High plasma leptin predicts an increase in subcutaneous adiposity in children and adults. Eur J Clin Nutr 2006 0.78
128 Puberty-associated differences in total cholesterol and triglyceride levels according to sex in French children aged 10-13 years. Ann Epidemiol 2000 0.78
129 Gender differences in the relation between fibrinogen, tissue-type plasminogen activator antigen and markers of insulin resistance: effects of smoking. D.E.S.I.R. Study Group. Data from an Epidemiological Study on Insulin Resistance Syndrome. Thromb Haemost 1999 0.77
130 Repeatability of the oral glucose tolerance test for the diagnosis of impaired glucose tolerance and diabetes mellitus. Diabetologia 1991 0.77
131 Therapeutic management of orally treated type 2 diabetic patients, by French general practitioners in 2010: the DIAttitude Study. Diabetes Metab 2012 0.76
132 Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721. Diabetologia 2007 0.76
133 Depressive symptoms, insulin sensitivity and insulin secretion in the RISC cohort study. Diabetes Metab 2012 0.76
134 Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes. Diabetologia 2012 0.76
135 Limitations of the correlation coefficient in the validation of diet assessment methods. CODIAB-INSERM-ZENECA Pharma Study Group. Epidemiology 1994 0.76
136 Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia. Br J Anaesth 2012 0.76
137 High death rate from neoplasms in French diabetic and non-diabetic men. Lancet 1998 0.75
138 Fasting blood glucose and risk of cardiovascular disease. Diabetes Care 1999 0.75
139 Pancreatic cancer and diabetes. N Engl J Med 1994 0.75
140 The epidemiology of coronary heart disease in glucose-intolerant and diabetic subjects. J Intern Med Suppl 1994 0.75
141 [Metabolic syndrome in childhood]. Journ Annu Diabetol Hotel Dieu 2005 0.75
142 [Larger waist circumference is a predictive factor for the occurrence of microalbuminuria in a non-diabetic population]. Arch Mal Coeur Vaiss 2006 0.75
143 Prevalence of non-insulin dependent diabetes as perceived by general practitioners in France. Rev Epidemiol Sante Publique 1995 0.75
144 Better analyze the determinants of therapeutic inertia to overcome it. Diabetes Metab 2012 0.75
145 Plasma glucose distributions in two pacific populations: the bimodality phenomenon. Tohoku J Exp Med 1983 0.75
146 [Study of the motivation of physicians participating in public health research]. Sante Publique 2002 0.75
147 The relationship between behavioural pattern, overall and central adiposity in a population of healthy French men. Int J Obes Relat Metab Disord 1993 0.75
148 Number of children and change in markers of metabolic health over 9-years in men and women. Data from the DESIR study. Diabetes Metab 2011 0.75
149 The French paradox and diabetic patients. Diabetes Care 1997 0.75
150 Characteristics associated with diabetic retinopathy in Nauruans. Tohoku J Exp Med 1983 0.75
151 [Revision of diagnostic criteria of diabetes. The reasons and the consequences]. Diabetes Metab 1998 0.75
152 Estimation of the prevalence of orally treated diabetes in France using a pharmacoepidemiologic approach: comparison between 1981 and 1992. Pharmacoepidemiol Drug Saf 1999 0.75
153 From policemen to policies: what is the future for 2-h glucose? The Kelly West Lecture, 2000. Diabetes Care 2001 0.75
154 Microalbuminuria and markers of the atherosclerotic process: the D.E. S.I.R. study. Atherosclerosis 2001 0.75
155 [Metabolic syndrome or insulin resistance syndrome. Recent epidemiological data]. Ann Endocrinol (Paris) 2003 0.75
156 Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAA. Diabetes Obes Metab 2013 0.75